classical hodgkin lymphoma
Showing 26 - 41 of 41
Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in Chicago (Pembrolizumab)
Recruiting
- Classical Hodgkin Lymphoma
- +3 more
-
Chicago, IllinoisUniversity of Chicago
Jun 29, 2021
B-CD30 + Hodgkin Lymphoma International Multi-center
Completed
- Classical Hodgkin Lymphoma
- Relapsed or Refractory Classical Hodgkin Lymphoma
-
Busan, Korea, Republic ofPusan National University Hospital
Jun 3, 2021
Classical Hodgkin Lymphoma Trial in Worldwide (cyclophosphamide, vincristine, prednisone, dacarbazine, cyclo, vcr, pred,
Active, not recruiting
- Classical Hodgkin Lymphoma
- cyclophosphamide, vincristine, prednisone, dacarbazine
- cyclo, vcr, pred, dacarb,etop and doxo
-
Victoria Park, Australia
- +18 more
May 10, 2021
Classical Hodgkin Lymphoma Trial in Atlanta, Columbus (drug, other, biological)
Active, not recruiting
- Classical Hodgkin Lymphoma
- Ibrutinib
- +2 more
-
Atlanta, Georgia
- +1 more
Mar 23, 2021
Classical Hodgkin Lymphoma Trial in Nanjing (Camrelizumab, Investigator's choice of Chemotherapy)
Recruiting
- Classical Hodgkin Lymphoma
- Camrelizumab
- Investigator's choice of Chemotherapy
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Feb 4, 2021
Classical Hodgkin Lymphoma Trial in Zhengzhou (Camrelizumab, Epirubicin, Vincristine)
Recruiting
- Classical Hodgkin Lymphoma
- Camrelizumab
- +3 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 29, 2020
Classical Hodgkin Lymphoma Trial in Cologne (Brentuximab Vedotin)
Recruiting
- Classical Hodgkin Lymphoma
- Brentuximab Vedotin
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Nov 26, 2020
Classical Hodgkin Lymphoma Trial in Chicago, Detroit, Seattle (Tenalisib, Pembrolizumab)
Terminated
- Classical Hodgkin Lymphoma
- Tenalisib
- Pembrolizumab
-
Chicago, Illinois
- +2 more
Dec 24, 2019
Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,
Unknown status
- Classical Hodgkin Lymphoma
- +3 more
- Adriamycin
- +5 more
-
Riyadh, Saudi ArabiaKing Abdulaziz Medical City, Ministry of National Guard
Nov 14, 2019
CLASSICAL HODGKIN LYMPHOMA Trial in Spain (Brentuximab Vedotin, Etoposide, Soludomerin)
Completed
- CLASSICAL HODGKIN LYMPHOMA
- Brentuximab Vedotin
- +4 more
-
Oviedo, Asturias, Spain
- +13 more
Apr 23, 2019
Classical Hodgkin Lymphoma Trial in Rouen (Digital Polymerase Chain Reaction)
Unknown status
- Classical Hodgkin Lymphoma
- Digital Polymerase Chain Reaction
-
Rouen, FranceCentre Henri Becquerel
Jul 20, 2018
Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Trial
Withdrawn
- Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
- +3 more
- Brentuximab Vedotin
- +2 more
- (no location specified)
Jan 12, 2018
Social Inequalities in Participation and Activity in Children
Unknown status
- Classical Hodgkin Lymphoma
- (no location specified)
Jun 20, 2016
Classical Hodgkin Lymphoma, Nodular Sclerosis, Mixed Cellularity Trial in Haifa (interim therapy scintigraphy study gallium scan
Completed
- Classical Hodgkin Lymphoma
- +4 more
- interim therapy scintigraphy study gallium scan or PET/CT
- "interim gallium or PET/CT"
-
Haifa, IsraelEldad Dann
Mar 20, 2006